The downregulation of EF2 in the tumor tissue of mice treated with pHGFK1 and pEndo + pHGFK1 nanoparticles suggests that pHGFK1 and the combination of pEndo + pHGFK1 could inhibit the protein synthesis of cancer cells. This evidence concerns the gene EEF2 and cancer.